KOLESTEATOM VARLIĞININ ÖNGÖRÜLEBİLMESİNDE KANDAKİ NÖTROFİL/LENFOSİT ORANININ ÖNEMİ

Year 2021, Volume: 54 Issue: 3, 419 - 423, 01.01.2022

Hasan Çanakcı , Kamil Gokce Tulacı

https://doi.org/10.20492/aeahtd.810162

Abstract

AMAÇ: Son yıllarda nötrofil/lenfosit oranı (NLO), platelet/lenfosit oranı (PLO) ve lenfosit/monosit oranı (LMO) oranları inflamasyonun bir göstergesi olarak çeşitli hastalıkların tanı ve takibinde kullanılmaktadır. Çalışmamızda da kronik otit hastalarında, inflamasyonla yakından ilişkili olduğu gösterilmiş olan kolesteatomun NLO, PLO ve LMO ile ilişkisinin incelenmesi amaçlanmıştır.
GEREÇ ve YÖNTEM: Kliniğimizde 2013-2019 yılları arasında kronik otit nedeniyle ameliyat edilen 138 hastanın dosyaları retrospektif olarak incelendi. Hastalar grup 1: kolesteatomlu kronik otit, grup 2: kolesteatomsuz kronik otit olarak sınıflandırıldı. Tüm hastaların yaş, cinsiyet, NLO, PLO, LMO verileri incelenerek kaydedildi ve gruplar arasında karşılaştırıldı.
BULGULAR: Grup 1’de 61 grup 2’de 77 hasta vardı. Gruplar arasında yaş ortalamaları açısından fark yoktu. Grup 1’de bayan hasta oranı grup 2 ye oranla daha düşüktü (p=0,042). Gruplar arasında kan hücrelerinin birbirine oranları incelendiğinde NLO, grup 1'de grup 2'ye göre anlamlı düzeyde yüksek izlenirken (p=0,006), PLO ve LMO da gruplar arasında istatistiksel açıdan anlamlı fark izlenmedi (sırasıyla p=0,913, p=0,111). NLO ≥1,734 kesme (cut-off) değeri, kolesteatom varlığını göstermede %75,4 duyarlılık ve %46,8 özgüllükte anlamlı olarak izlendi.
SONUÇ: Çalışmamızda farklı hastalıkların tanı ve takiplerinde inflamasyon göstergesi olarak anlamlı bilgiler verdiği gösterilen NLO’nın kolesteatom varlığını tahmin etmede de anlamlı olduğu görülmüştür. Kronik otit ve eşlik eden retraksiyon, adezyon veya sık enfeksiyon şikâyeti olan ve timpanoplasti sonrası nüks veya rezidü kolesteatom açısından risk taşıyan bireylerin takiplerinde NLO’nın değerlendirilmesinin hastaların takipleri açısından faydalı olabileceğini düşünmekteyiz.

Keywords

Kolesteatom, Nötrofil, Lenfosit, kronik otitis media

References

• 1. Quaranta A, Bartoli R, Lozupone E, et al. Cholesteatoma in children: histopathologic findings in middle ear ossicles. ORL J Otorhinolaryngol Relat Spec. 1995; 57(5): 296-8. doi: 10.1159/000276762.
• 2. Kuo CL. Etiopathogenesis of acquired cholesteatoma: prominent theories and recent advances in biomolecular research. Laryngoscope. 2015; 125(1): 234-40.
• 3. Aberg B, Westin T, Tjellström A, et al. Clinical characteristics of cholesteatoma. Am J Otolaryngol. 1991; 12(5): 254-8. doi: 10.1016/0196-0709(91)90002-w.
• 4. Olszewska E, Wagner M, Bernal-Sprekelsen M, et al. Etiopathogenesis of cholesteatoma. Eur Arch Otorhinolaryngol. 2004; 261(1): 6-24. doi:10.1007/s00405-003-0623-x.
• 5. Louw L. Acquired cholesteatoma pathogenesis: stepwise explanations. J Laryngol Otol. 2010; 124(6): 587-93. doi: 10.1017/S0022215109992763.
• 6. Russell CD, Parajuli A, Gale HJ, et al. The utility of peripheral blood leucocyte as biomarkers in infectious diseases: a systematic review and meta-analysis. J Infect. 2019; 78(5): 339–48. doi:10.1016/j.jinf.2019.02.006.
• 7. Sarikaya M, Dogan Z, Ergul B, et al. Neutrophil-to-lymphocyte ratio as a sensitive marker in diagnosis of celiac disease. Ann Gastroenterol. 2014; 27: 431–2.
• 8. Hajibandeh S, Hobbs N, Mansour M, et al. Neutrophil-tolymphocyte ratio predicts acute appendicitis and distinguishes between complicated and uncomplicated appendicitis: a systematic review and meta-analysis. Am J Surg. 2020; 219(1): 154–63. doi:10.1016/j.amjsurg.2019.04.018.
• 9. Sun Y, Lin J, Luo Z, et al. Preoperative Lymphocyte to Monocyte Ratio Can Be a Prognostic Factor in Arthroscopic Repair of Small to Large Rotator Cuff Tears. Am J Sports Med. 2020; 48(12):3042-50. doi: 10.1177/0363546520953427.
• 10. Yue S, Zhang J, Wu J, et al. Use of the Monocyte-to-Lymphocyte Ratio to Predict Diabetic Retinopathy. Int J Environ Res Public Health. 2015; 12(8): 10009-19. doi: 10.3390/ijerph120810009.
• 11. Imtiaz F, Shafique K, Mirza SS, et al. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int Arch Med. 2012; 5(1): 2. doi:10.1186/1755-7682-5-2.
• 12. Kuo CL, Liao WH, Shiao AS. A review of current progress in acquired cholesteatoma management. Eur Arch Otorhinolaryngol 2015; 272(12): 3601-9.
• 13. Yung M, Tono T, Olszewska E, et al. EAONO/JOS Joint Consensus Statements on the Definitions, Classification and Staging of Middle Ear Cholesteatoma. J Int Adv Otol. 2017; 13(1): 1-8. doi:10.5152/iao.2017.3363.
• 14. Nitz WR. Fast and ultrafast non-echo-planar MR imaging techniques. Eur Radiol. 2002; 12: 2866-82.
• 15. van Egmond SL, Stegeman I, Grolman W, et al. A Systematic Review of Non-Echo Planar Diffusion-Weighted Magnetic Resonance Imaging for Detection of Primary and Postoperative Cholesteatoma. Otolaryngol Head Neck Surg. 2016; 154(2): 233-40. doi: 10.1177/0194599815613073.
• 16. Meyerhoff WL, Wright CG, Gerken GM. Effects of middle ear ventilation on cholesteatoma development in experimental animals. Acta Otolaryngol. 1990; 110(3-4): 279-85. doi:10.3109/00016489009122549.
• 17. Heumann A, Steinbach E, Koneberg F. Untersuchung zur Cholesteatomentstehung durch Verschluss der Tube bei Kaninchen. Arch Oto-Rhino-Laryngol 1981; 231: 813-15.
• 18. Tos M. Upon the relationship between secretory otitis in childhood and chronic otitis and its sequelae in adults. J Laryngol Otol. 1981; 95: 1011–22.
• 19. Escher F. Die Therapie des Mittelohrcholesteatoms. HNO. 1979; 27: 145–149.
• 20. Steinbach E, Pusalkar A, Heumann H. Cholesteatoma—pathology and treatment. Adv Oto-Rhino-Laryngol. 1988; 39: 94–106.
• 21. Ruedi L. Pathogenesis and surgical treatment of the middle ear cholesteatoma. Acta Otolaryngol. 1978; 361(Suppl): 1–45.
• 22. Schwartz M (1984) Die genetischen Faktoren des Mittelohrcholesteatoms. HNO. 1984; 32: 59–60.
• 23. Louw L. Acquired cholesteatoma: summary of the cascade of molecular events. J Laryngol Otol. 2013; 127(6): 542–49.
• 24. Li N, Qin ZB. Inflammation-induced miR-802 promotes cell proliferation in cholesteatoma. Biotechnol Lett. 2014; 36(9): 1753–9.
• 25. Si Y, Chen YB, Chen SJ, et al. TLR4 drives the pathogenesis of acquired cholesteatoma by promoting local inflammation and bone destruction. Sci Rep. 2015; 5: 16683.
• 26. Azab B, Zaher M, Weiserbs KF, et al. Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction. Am J Cardiol. 2010; 106(4): 470-6. doi: 10.1016/j.amjcard.2010.03.062.
• 27. Azab B, Bhatt VR, Phookan J, et al. Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann Surg Oncol. 2012; 19(1): 217-24. doi: 10.1245/s10434-011-1814-0.
• 28. Liu X, Zhang Q, Wu H, et al. Blood Neutrophil to Lymphocyte Ratio as a Predictor of Hypertension. Am J Hypertens. 2015; 28(11): 1339-46. doi: 10.1093/ajh/hpv034.
• 29. Wang Q, Ma J, Jiang Z, et al. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute pulmonary embolism: a systematic review and meta-analysis. Int Angiol. 2018; 37(1): 4-11. doi:10.23736/S0392-9590.17.03848-2.
• 30. Stotz M, Gerger A, Eisner F, et al. Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer. 2013; 109(2): 416-21. doi: 10.1038/bjc.2013.332.
• 31. Seo YJ, Jeong JH, Choi JY, et al. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio: novel markers for diagnosis and prognosis in patients with idiopathic sudden sensorineural hearing loss. Dis Markers 2014; 2014: 702807.
• 32. Chung JH, Lim J, Jeong JH, et al. The significance of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in vestibular neuritis. Laryngoscope 2015; 125: 257-61.
• 33. Bucak A, Ulu S, Oruc S, et al. Neutrophil- to-lymphocyte ratio as a novel-potential marker for predicting prognosis of Bell palsy. Laryngoscope 2014; 124: 1678–81.
• 34. Özler GS, Günak G. Neutrophil-lymphocyte ratio: a new predictive and prognostic factor in patients with Bell palsy. J Craniofac Surg 2014; 25: 944-5.
• 35. Ziai WC, Torbey MT, Kickler TS, et al. Platelet count and function in spontaneous intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2003; 12: 201-6.
• 36. Azab B, Shah N, Akerman M, et al. Value of platelet/lymphocyte ratio as a predictor of all cause mortality after non-ST-elevation myocardial infarction. J Thromb Thrombolysis. 2012; 34: 326-34.
• 37. Bulgurcu S, Arslan IB, Dikilitas B, et al. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in malignant and precancerous laryngeal lesions. Kulak Burun Bogaz Ihtis Derg. 2017; 27: 122-7.
• 38. Boztepe OF, Demir M, Gün T, et al. A novel predictive marker for the viscosity of otitis media with effusion. Int J Pediatr Otorhinolaryngol. 2015; 79: 2355-8.
• 39. Elbistanli MS, Koçak HE, Acipayam H, et al. The Predictive Value of Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratio for the Effusion Viscosity in Otitis Media With Chronic Effusion. J Craniofac Surg. 2017 May; 28(3): e244-e247. doi: 10.1097/SCS.0000000000003452.
• 40. Eryilmaz MA, Derin S. Mean Platelet Volume as a Potential Predictor of Cholesteatoma in Children. J Craniofac Surg. 2016; 27(6): e575-8. doi: 10.1097/SCS.0000000000002881.
• 41. Kılıçkaya MM, Aynali G, Tuz M, et al. Is There A Systemıc Inflammatory Effect of Cholesteatoma? Int Arch Otorhinolaryngol. 2017; 21(1): 42-5. doi: 10.1055/s-0036-1584363.